Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXL01652	盐酸托泊替康胶囊	topotecan hydrochloride	Capsule	Chemical Drugs(4)	New Drug Application	2001-07-30	史克必成（天津）有限公司	Glaxo Smith Kline Tianjin Co Ltd	Certificate Issued	2002-02-26	view
CXL01653	盐酸托泊替康胶囊	topotecan hydrochloride	Capsule	Chemical Drugs(4)	New Drug Application	2001-07-30	史克必成（天津）有限公司	Glaxo Smith Kline Tianjin Co Ltd			view
CXHS0500716	盐酸拓扑替康胶囊	topotecan hydrochloride	Capsule	Chemical Drugs	New Drug Application	2005-04-07	南京瑞年双科制药有限公司	Nanjing Ruinian Bai Si Te Pharmaceutical Co Ltd	Certificate Issued	2007-09-19	view
CXHS0500715	盐酸拓扑替康胶囊	topotecan hydrochloride	Capsule	Chemical Drugs	New Drug Application	2005-04-07	南京瑞年双科制药有限公司	Nanjing Ruinian Bai Si Te Pharmaceutical Co Ltd	Certificate Issued	2007-09-19	view
CYHB1204707	盐酸拓扑替康胶囊	topotecan hydrochloride	Capsule	Chemical Drugs	Supplementary Application	2012-08-20	南京瑞年百思特制药有限公司	Nanjing Ruinian Bai Si Te Pharmaceutical Co Ltd	Certificate Issued	2013-07-09	view